- Home
- GHRS vs FDUS Comparison
GHRS vs FDUS Comparison
Compare GHRS & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- FDUS
- Stock Information
- Founded
- GHRS 2018
- FDUS 2011
- Country
- GHRS Ireland
- FDUS United States
- Employees
- GHRS N/A
- FDUS N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- FDUS Finance/Investors Services
- Sector
- GHRS Health Care
- FDUS Finance
- Exchange
- GHRS Nasdaq
- FDUS Nasdaq
- Market Cap
- GHRS 774.1M
- FDUS 745.8M
- IPO Year
- GHRS 2021
- FDUS 2011
- Fundamental
- Price
- GHRS $13.53
- FDUS $20.60
- Analyst Decision
- GHRS Strong Buy
- FDUS Buy
- Analyst Count
- GHRS 9
- FDUS 3
- Target Price
- GHRS $29.33
- FDUS $21.67
- AVG Volume (30 Days)
- GHRS 274.3K
- FDUS 207.2K
- Earning Date
- GHRS 11-07-2025
- FDUS 11-06-2025
- Dividend Yield
- GHRS N/A
- FDUS 10.97%
- EPS Growth
- GHRS N/A
- FDUS N/A
- EPS
- GHRS N/A
- FDUS 2.31
- Revenue
- GHRS N/A
- FDUS $152,305,000.00
- Revenue This Year
- GHRS N/A
- FDUS $6.31
- Revenue Next Year
- GHRS N/A
- FDUS $5.37
- P/E Ratio
- GHRS N/A
- FDUS $8.90
- Revenue Growth
- GHRS N/A
- FDUS 8.16
- 52 Week Low
- GHRS $6.72
- FDUS $16.70
- 52 Week High
- GHRS $20.50
- FDUS $23.55
- Technical
- Relative Strength Index (RSI)
- GHRS 50.01
- FDUS 52.49
- Support Level
- GHRS $12.50
- FDUS $20.25
- Resistance Level
- GHRS $14.44
- FDUS $20.75
- Average True Range (ATR)
- GHRS 1.04
- FDUS 0.37
- MACD
- GHRS 0.01
- FDUS 0.06
- Stochastic Oscillator
- GHRS 45.24
- FDUS 62.34
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.